Simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide by spectrophotometry in tablet formulation.

Raman N Kachave, Rajendra N Bhadane, Rajendra Wagh, Deepti. Jain

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Sammanfattning

Two precise, accurate, sensitive spectrophotometric methods was developed and validated for the simultaneous estn. of olmesartan medoxomil (OLM) and hydrochlorothiazide (HCT) in tablet formulation. In dual wavelength method absorbance difference at 254.8 nm and 284 nm were considered for estn. of OLM while HCT was estd. as single component at 322 nm. In simultaneous equation method estn. of OLM and HCT was carried out at 249 nm and 273.5 nm resp. Regression anal. of beers plots showed good correlation in concn. range of 0-25 μg/mL for OLM and HCT resp. Accuracy was detd. by recovery studies from tablet dosages form and ranges from 98-101%. Precision of method was find out as repeatability, day to day and analyst to analyst variation and shows the values within limit (R.S.D. ≤ 2). [on SciFinder(R)]
OriginalspråkEngelska
Sidor (från-till)1047-1049
Antal sidor3
TidskriftResearch Journal of Pharmacy and Technology
Volym3
Nummer4
StatusPublicerad - 2010
MoE-publikationstypA1 Tidskriftsartikel-refererad

Fingeravtryck

Fördjupa i forskningsämnen för ”Simultaneous estimation of olmesartan medoxomil and hydrochlorothiazide by spectrophotometry in tablet formulation.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här